Videos |View More
Previously recorded: Tuesday, November 15, 2022 | 5-6 PM EST
Following a national search, Roswell Park Comprehensive Cancer Center has appointed Marco Davila, MD, PhD, as Senior Vice President and Associate Director for Translational Research and Vice-Chair for Cellular Therapies.
A team from Roswell Park Comprehensive Cancer Center has detailed striking findings on the effectiveness of a previously untried combination of old and new drugs as treatment for recurrent ovarian cancer.
In this lecture, Katherine LaVigne Mager, MD, discusses fertility sparing treatment in gynecologic oncology. Infertility is a common side effect of cancer treatment for many cancer types. Fertility preservation is very important to younger ...
News |View More
Findings point to features of therapeutic response and potential biomarkers
Researchers from Roswell Park Comprehensive Cancer Center report that a new approach to immunotherapy could overcome some of the challenges of treating ovarian cancer by leveraging the power of endogenous (host) T cells using engineered ...
Researchers at Roswell Park Comprehensive Cancer Center have launched a randomized, phase 2 clinical trial that they hope will improve both survival and quality of life for patients with recurrent ovarian, fallopian tube or primary peritoneal ...
This site is intended for healthcare professionals